- Home
- Free App Analytics
- AnthroCalc
- AnthroCalc Vs. Firstline - Clinical Decisions
AnthroCalc vs Firstline - Clinical Decisions Usage & Stats
The AnthroCalc app calculates percentiles and Z-scores for length/height, weight, weight-for-length/height, body-mass index, and head circumference for typically growing children (using WHO or CDC references); for children with a number of syndromes (Turner, Down, Prader–Willi, Russell–Silver and Noonan); and for preterm infants (using Fenton, INTERGROWTH-21st, or Olsen references). The app also performs specialized calculations of blood pressure (using NIH 2004 or AAP 2017 references), extended obesity measures, waist circumference, arm circumference, triceps and subscapular skinfolds, target (midparental) height, predicted adult height, and height velocity for healthy children. Citations are provided for each reference range used for the calculations.
- Apple App Store
- Free
- Medical
Store Rank
- -
Healthcare organizations worldwide rely on Firstline to deliver customized, interactive guidance directly to the point of care, making it easy for healthcare providers to choose the best treatment for their patients.
Features:
• Customizable for any hospital or healthcare organization
• Antimicrobial stewardship guidelines
• Infection Prevention & Control protocols
• Antimicrobial formulary information
• Pathogen information including local antibiogram data
• Messaging system with push notifications
• Integrated calculators
• Surveys and forms
• Cloud-based, rapid updates
• Works offline
- Apple App Store
- Free
- Medical
Store Rank
- -
AnthroCalc vs. Firstline - Clinical Decisions ranking comparison
Compare AnthroCalc ranking trend in the past 28 days vs. Firstline - Clinical Decisions
Rank
No Data Available
AnthroCalc vs. Firstline - Clinical Decisions ranking by country comparison
Compare AnthroCalc ranking trend in the past 28 days vs. Firstline - Clinical Decisions
All categories
No Data Available
Medical
Compare to any site with our free trial
AnthroCalc VS.
Firstline - Clinical Decisions
December 30, 2024